FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Metoprolol tartrate (as metoprolol succinate) 25 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely metoprolol tartrate (as metoprolol succinate) 100 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely metoprolol tartrate (as metoprolol succinate) 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely metoprolol tartrate (as metoprolol succinate) 200 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely metoprolol tartrate (as metoprolol succinate) 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely selinexor 20 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely selinexor 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely burosumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely burosumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely burosumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely burosumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely burosumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely burosumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely luspatercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely luspatercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely luspatercept 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely luspatercept 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Vaccine product containing only Neisseria meningitidis serogroup C capsular polysaccharide conjugated antigen (medicinal product) Count of active ingredient False 1 Inferred relationship Some
    Vaccine product containing only Neisseria meningitidis serogroup C antigen (medicinal product) Count of active ingredient False 1 Inferred relationship Some
    Polyestradiol only product Count of base of active ingredient False 1 Inferred relationship Some
    Fostemsavir only product Count of base of active ingredient False 1 Inferred relationship Some
    Fostemsavir only product in oral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely fostemsavir 600 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely fostemsavir 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely mebendazole 500 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely mebendazole 500 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely triclabendazole 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely triclabendazole 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Benznidazole 100 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Benznidazole 100 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Benznidazole 12.5 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Benznidazole 12.5 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely clindamycin (as clindamycin palmitate hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely clindamycin (as clindamycin palmitate hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely abiraterone acetate 500 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely abiraterone acetate 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Triclabendazole 250 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Triclabendazole 250 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Benzylpenicillin (as benzylpenicillin potassium) 5 million unit powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Benzylpenicillin (as benzylpenicillin potassium) 5 million unit powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cedazuridine 100 mg and decitabine 35 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cedazuridine 100 mg and decitabine 35 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Miltefosine 50 mg oral capsule Count of base of active ingredient False 1 Inferred relationship Some
    Miltefosine 50 mg oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely miltefosine 10 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely miltefosine 10 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amphotericin B liposome 50 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Amphotericin B liposome 50 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 3
    Product containing precisely ledipasvir 90 milligram and sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ledipasvir 90 milligram and sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Sofosbuvir 400 mg and velpatasvir 100 mg oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Sofosbuvir 400 mg and velpatasvir 100 mg oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely glecaprevir 100 milligram and pibrentasvir 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely glecaprevir 100 milligram and pibrentasvir 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Brexucabtagene autoleucel only product Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only brexucabtagene autoleucel in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely afatinib (as afatinib dimaleate) 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely afatinib (as afatinib dimaleate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Agomelatine 25 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Agomelatine 25 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely phenazone 50 milligram/1 milliliter conventional release solution for ear drops (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely phenazone 50 milligram/1 milliliter conventional release solution for ear drops (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Bisacodyl 2 mg/mL rectal suspension Count of base of active ingredient False 1 Inferred relationship Some
    Bisacodyl 2 mg/mL rectal suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing only agomelatine in oral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only phenazone in otic dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Cinnarizine 25 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Cinnarizine 25 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely capecitabine 300 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely capecitabine 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Brivaracetam 75 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Brivaracetam 75 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Brivaracetam 50 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Brivaracetam 50 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Brivaracetam 25 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Brivaracetam 25 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely brivaracetam 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely brivaracetam 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Brivaracetam 100 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Brivaracetam 100 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Brigatinib 30 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Brigatinib 30 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely brigatinib 180 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely brigatinib 180 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely brigatinib 90 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely brigatinib 90 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Binimetinib 15 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Binimetinib 15 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Baricitinib 2 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some

    Start Previous Page 211 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start